| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$33 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2024 9:35AM |
$0.880 |
$0.295 |
fallen by
66.48%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- LTR Pharma's SPONTAN® nasal spray for erectile dysfunction shows rapid absorption and faster onset of action compared to oral PDE5 inhibitors.
- SPONTAN® delivered peak drug concentration (Cmax) at half the dose of oral tablets and reached peak concentration (Tmax) in as little as 9 minutes.
- No serious adverse events reported with SPONTAN.
- As of 30 June 2024, LTR Pharma held a cash balance of $3.10 million.
- Post quarter-end, LTR Pharma raised $10.5 million through a share placement.
- Net cash used in operating activities for the quarter was $2.18 million.
- Financial update highlights an operational cash burn closely aligned with the prospectus, adjusting for one-off payments.
- The capital raise is intended to fund ongoing operations, research and development, and commercial pathways.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SPDR S&P/ASX 200 Fund (STW) |
Financials |
$6,001 |
Notice of Director Resignation
|
29 Jul 2024 9:35AM |
$71.820 |
$76.950 |
risen by
7.14%
|
|
| SPDR S&P/ASX 200 Listed Property Fund (SLF) |
Financials |
$578 |
Notice of Director Resignation
|
29 Jul 2024 9:35AM |
$12.970 |
$14.090 |
risen by
8.64%
|
|
| SPDR S&P/ASX 50 Fund (SFY) |
Financials |
$778 |
Notice of Director Resignation
|
29 Jul 2024 9:35AM |
$71.000 |
$75.370 |
risen by
6.15%
|
|
| Avenira Limited (AEV) ORDINARY FULLY PAID |
Materials |
$32 |
Extension of Voluntary Suspension
|
29 Jul 2024 9:35AM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
| Noble Helium Limited (NHE) ORDINARY FULLY PAID |
Energy |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2024 9:35AM |
$0.059 |
$0.019 |
fallen by
67.80%
|
|
NHE - Price-sensitive ASX Announcement
Full Release
Key Points
- Mbelele shallow, free gas cap zone shows commercial production potential.
- Appointment of experienced petroleum engineer Mr. Dermot O’Keeffe as Chief Operating Officer.
- Receipt of the first Tanzanian VAT refund of $1.285 million.
- Eight additional potential shallow free gas helium targets identified within the Western Rukwa Upper Lake Beds zone.
- The quarterly share purchase plan raised $739,000.
- Major expenses were on exploration & evaluation ($1.42m), interest & other financing costs ($0.24m), and administration & corporate costs ($0.42m).
- Consolidated cash at hand was $2.26 million as of 30 June 2024.
- Significant cash flow details and financing activities outlined in the Appendix 5B report.
- First VAT refund not required to repay VAT Loan under the agreement terms.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kalgoorlie Gold Mining Limited (KAL) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - KAL
|
29 Jul 2024 9:34AM |
$0.026 |
$0.040 |
risen by
53.85%
|
|
| Kalgoorlie Gold Mining Limited (KAL) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - KAL
|
29 Jul 2024 9:34AM |
$0.026 |
$0.040 |
risen by
53.85%
|
|
| Vital Metals Limited (VML) ORDINARY FULLY PAID |
Materials |
$12 |
Quarterly Activities and Cash Flow Report
|
29 Jul 2024 9:34AM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
VML - Price-sensitive ASX Announcement
Full Release
Key Points
- Vital Metals Limited held approximately $3.71 million in cash as of June 30, 2024.
- The company made payments of $224,000 to related parties during the quarter, related to director remuneration.
- Vital spent $459,000 on exploration and evaluation expenditure during the quarter.
- Drilling at the Tardiff deposit returned significant high-grade intersections including: 53.5m at 1.5% TREO from 6.7m, and 55.0m at 1.6% TREO from 20.5m.
- Vital received C$3 million for rare earth material sold to the Saskatchewan Research Council.
- The company is updating the Tardiff Mineral Resource Estimate, with completion expected in Q4 2024.
- Focused study updates and a scoping study for the Tardiff deposit are planned for late 2024.
- Camp remediation costs were incurred due to damage from wildlife during a wildfire evacuation.
- Significant milestones include achieving high-grade drilling results and updating mineral resource estimates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kalgoorlie Gold Mining Limited (KAL) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - KAL
|
29 Jul 2024 9:34AM |
$0.026 |
$0.040 |
risen by
53.85%
|
|
| Kalgoorlie Gold Mining Limited (KAL) ORDINARY FULLY PAID |
Materials |
$15 |
$2.3 million Placement and $0.5 million SPP
|
29 Jul 2024 9:33AM |
$0.026 |
$0.040 |
risen by
53.85%
|
|
KAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Kalgoorlie Gold Mining Limited (ASX: KAL) announces $2.3 million placement and $0.5 million Share Purchase Plan (SPP).
- The placement will be executed in two tranches and supported by existing and new investors.
- New shares under the placement and SPP will be issued at $0.026 per share with an attached 1 for 1 unquoted option.
- Directors have agreed to subscribe for $50,000 in the placement, subject to shareholder approval.
- Funds will be used to accelerate drilling and satisfy farm-in commitments at the Pinjin project.
- Shareholders can apply for up to $30,000 of new shares through the SPP without brokerage fees.
- The placement includes a provision for bonus options for shares exercised within the first 12 months.
- General Meeting for shareholder approval expected in September 2024.
- The SPP offer period will be from 7 August 2024 to 30 August 2024.
- Joint Lead Managers for the placement are Palomar Advisory Pty Ltd and Peak Asset Management Pty Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Desert Metals Limited (DM1) ORDINARY FULLY PAID |
Materials |
$9 |
Significant gold anomalies identified at Tengrela South
|
29 Jul 2024 9:33AM |
$0.030 |
$0.021 |
fallen by
30%
|
|
DM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Two distinct parallel north-south gold anomalies identified at Tiogo and Kakologo.
- Gold anomalies extend for 3.6km and 2.1km respectively.
- Peak gold values of 32.7g/t, 12.6g/t, and 7.84g/t identified from soil samples.
- 1,646 soil samples collected over 18km².
- Further aircore drilling planned to test in-situ gold mineralisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tyranna Resources Limited (TYX) ORDINARY FULLY PAID |
Materials |
$16 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2024 9:33AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
TYX - Price-sensitive ASX Announcement
Full Release
Key Points
- 15 drill holes were completed, totaling 2,555 meters.
- High-grade spodumene pegmatites were intersected.
- Best assay results include MRC37 intersecting 23m at 2.42% Li2O from 21m.
- Drilling will resume in the second half of 2024, focusing on lithium-mineral pegmatites.
- Muvero project is fully funded by Sinomine Resources (Hainan) Lithium Co., Ltd.
- Tyranna Resources has cash reserves of $7.45 million and no debt as of the end of June 2024.
- Board restructure was announced with David Crook appointed as Managing Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$49 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2024 9:32AM |
$0.036 |
$0.027 |
fallen by
25%
|
|
LKE - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic Partner Process and Production Environmental Impact Assessment (EIA) progress for Kachi Project
- Non-binding Letter of Intent with YPF Luz for power supply to Kachi Project
- Lowest quarterly cash expenditures in over two years
- Raised $1.5 million from Shareholder Purchase Plan (SPP) and $2.5 million from At-The-Market facility
- Submission of EIA to Catamarca Mining Authority and engagement with local authorities
- Net cash used in operating activities was $6.553 million
- Payments for exploration and evaluation classified as investing activities totaled $1.289 million
- Cash and cash equivalents at the end of the quarter were $22.902 million
- Total available funding was $25.502 million with estimated quarters of funding available at 3.25
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alicanto Minerals Limited (AQI) ORDINARY FULLY PAID |
Materials |
$24 |
Application for quotation of securities - AQI
|
29 Jul 2024 9:32AM |
$0.023 |
$0.028 |
risen by
21.74%
|
|
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$9,217 |
Preliminary Final Results
|
29 Jul 2024 9:32AM |
$7.310 |
$7.350 |
risen by
0.55%
|
|
AFI - Price-sensitive ASX Announcement
Full Release
Key Points
- Full Year Profit of $296.4 million, down from $310.2 million last year.
- Decline due to lower dividends from BHP, Rio Tinto, and Woodside Energy Group.
- Earnings per share: 23.75 cents.
- Final dividend increased to 14.5 cents per share fully franked.
- Total fully franked dividends for the year: 26.0 cents per share.
- Portfolio returned 15.1%, outperforming the S&P/ASX 200 Accumulation Index's 13.5% return.
- Strongest contributors: CAR Group, Goodman Group, Wesfarmers, Reece, Netwealth, ARB Corporation.
- Managed a global portfolio valued at $147.5 million, representing about 1.5% of the total portfolio.
- Strategic activities included increasing positions in existing holdings like Woodside Energy and BHP.
- Initiated new positions in Mineral Resources and Macquarie Technology Group.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qmines Limited (QML) ORDINARY FULLY PAID |
Materials |
$19 |
Mt Chalmers Mining License Update
|
29 Jul 2024 9:32AM |
$0.052 |
$0.043 |
fallen by
17.31%
|
|
QML - Price-sensitive ASX Announcement
Full Release
Key Points
- QMines Limited updates on Mt Chalmers copper and gold project
- Mount Chalmers project located 17km north-east of Rockhampton, Queensland
- Completed pre-lodgement of the Mining Lease Application for Mount Chalmers
- Department of Resources satisfied with application, Mining Lease number ML 100403 allocated
- Mt Chalmers Pre-Feasibility Study and Maiden Ore Reserve estimate delivered on 30th April 2024
- Proved and Probable category with a total ore reserve of 9.6 Mt, 62,600t Cu, 147,600oz Au
- Project demonstrates a long life, low cost and high margin mining operation
- Immediate upside with five additional deposits at Mt Chalmers and Develin Creek projects
- Preparing to commence maiden drilling program at Develin Creek project
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G11 Resources Limited (G11) ORDINARY FULLY PAID |
Materials |
$16 |
G11 June 2024 Quarterly Activities Report & Appendix 5B
|
29 Jul 2024 9:31AM |
$0.019 |
$0.017 |
fallen by
10.53%
|
|
G11 - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade copper intersections at Wilandra Copper Project.
- Significant drill results, including 9m at 2.68% Cu and 6m at 3.46% Cu.
- EM surveys confirmed a distinct electromagnetic signature from high-grade shoots.
- Expanded drill program to test additional high-grade shoots over 4.5km strike area.
- Reinterpretation of airborne EM datasets identified new anomalies.
- AUD 704K spent on exploration during the reporting period.
- Company had AUD 1.09M in cash at the end of the quarter.
- Appointment of Richard Buerger as Managing Director and Chief Executive Officer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$2,763 |
Investor Webcast - June 2024 Quarterly Results
|
29 Jul 2024 9:31AM |
$2.560 |
$2.930 |
risen by
14.45%
|
|
| Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$2 |
Further update on PAT-DX1 GMP manufacturing run
|
29 Jul 2024 9:31AM |
$0.007 |
$0.001 |
fallen by
85.71%
|
|
PAB - Price-sensitive ASX Announcement
Full Release
Key Points
- Patrys Limited provided an update on their recently completed GMP manufacturing run of PAT-DX1.
- An inconsistency was identified in one of the processes used in specification testing.
- The CDMO is addressing the inconsistency with specification testing expected to be completed by August 2024.
- Successful completion of specification testing is crucial for releasing the drug material for clinical trials.
- Delays in specification testing and drug release impact the commencement of clinical development activities for PAT-DX1.
- The company will provide further updates if there are any changes in the timeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$18 |
Jun 24 Quarterly Activities Report and Appendix 4C
|
29 Jul 2024 9:30AM |
$0.056 |
$0.062 |
risen by
10.71%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant progress on re-engineering ColoSTAT® assay into a simpler, higher quality multiplex antibody assay
- Update of clinical strategy to include triage for patients symptomatic for bowel disease and at higher-than-average risk of colon cancer
- Upgrade of quality systems with migration to eQMS and team strengthening
- Board composition review initiated and engagement of third party for assessment
- Rights Issue closed raising a total of ~$2.75m
- Concluding deliberations with Tax Advisers and Auditors regarding R&D Tax Incentive claim
- Preparation of the R&D Tax Incentive Claim for FY24 underway
- Work commenced on establishing a Financing Facility secured against RDTI refunds
- Engagement of Quansys to develop a multiplex version of ColoSTAT®
- Operations and Project Manager recruited for development program oversight
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$486 |
Trading Halt
|
29 Jul 2024 9:30AM |
$0.260 |
$0.205 |
fallen by
21.15%
|
|
LOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Lotus Resources Limited (ASX: LOT) securities placed in trading halt at the company's request.
- Trading halt pending the release of an announcement regarding a material agreement.
- Expected announcement about a Mine Development Agreement with the Government of Malawi.
- Trading halt effective from 29 July 2024.
- Trading to resume either on 31 July 2024 or upon announcement release.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mineral Commodities Limited (MRC) ORDINARY FULLY PAID |
Materials |
$26 |
Trading Halt
|
29 Jul 2024 9:29AM |
$0.026 |
$0.026 |
fallen by
0%
|
|
MRC - Price-sensitive ASX Announcement
Full Release
Key Points
- MRC requests a trading halt due to a major environmental incident.
- Trading halt effective immediately from Monday, 29 July 2024.
- Halt will end upon announcement release or normal trading start on 31 July 2024.
- Company unaware of additional information or reasons to deny the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
$43 |
Psychiatry professor David Castle appointed to TYPs SAB
|
29 Jul 2024 9:29AM |
$0.020 |
$0.031 |
risen by
55%
|
|
| Metalicity Limited (MCT) ORDINARY FULLY PAID |
Materials |
- |
Trading Halt
|
29 Jul 2024 9:29AM |
$0.003 |
$0.031 |
risen by
933.33%
|
|
MCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Metalicity Limited (ASX: MCT) requested a trading halt pending a capital raising announcement.
- The trading halt is in effect from 29 July 2024 until the earlier of the announcement release or the commencement of normal trading on 31 July 2024.
- The company expects the trading halt to end with the release of the announcement.
- Metalicity Limited confirmed there is no other information necessary for the market or requested by ASX regarding the suspension.
- The request was made in accordance with ASX Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
